These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2087009)

  • 1. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
    Fujimura T; Shibata H; Maekawa I; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Jpn J Pharmacol; 1990 Dec; 54(4):464-7. PubMed ID: 2087009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.
    Fujimura T; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):235-8. PubMed ID: 2047569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis.
    Furusawa S; Wu J; Fujimura T; Nakano S; Nemoto S; Takayanagi M; Sasaki K; Takayanagi Y
    Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):87-97. PubMed ID: 9604850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assay of flow cytometry for the effect of cepharanthine on resistance to doxorubicin].
    Kisara S; Hayashi A; Maekawa I; Furusawa S; Takayanagi Y; Sasaki K
    Yakugaku Zasshi; 1992 Nov; 112(11):837-45. PubMed ID: 1484349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells.
    Viladkar A; Chitnis M
    Cancer Biother; 1994; 9(2):143-51. PubMed ID: 7812363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T; Suzumura Y
    J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
    Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
    Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
    Chitnis MP; Viladkar AB; Juvekar AS
    Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
    Cuvier C; Roblot-Treupel L; Millot JM; Lizard G; Chevillard S; Manfait M; Couvreur P; Poupon MF
    Biochem Pharmacol; 1992 Aug; 44(3):509-17. PubMed ID: 1354963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium (Se) cytotoxicity in drug sensitive and drug resistant murine tumour.
    Shallom J; Juvekar A; Chitnis M
    Cancer Biother; 1995; 10(3):243-8. PubMed ID: 8547963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modulation of anthracycline resistance by reserpine in P388 leukemia cells].
    Shibata H; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):1-6. PubMed ID: 1889760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine.
    Viladkar A; Chitnis M
    Cancer Biother; 1993; 8(1):77-85. PubMed ID: 7812352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.